Immune modulation, disease resistance and growth performance of Indian farmed carp, Labeo rohita (Hamilton), in response to dietary consortium of putative lactic acid bacteria

Maji, Usha Jyoti; Mohanty, Sujata; Pradhan, Avinash; Maiti, N. K.

doi:10.1007/s10499-017-0122-5

Cited by 20 publications

(18 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The immunostimulant effects of a mixture of two different LAB were also investigated. These studies revealed that the mixture LAB were superior to a single homogenous LAB in the probiotic effects (Beck et al, 2015 ; Maji et al, 2017 ). Not only various strains of LAB, but diverse species of subject fish were investigated as well; olive flounder, Nile tilapia, shirbot, Huanghe common carp ( C. carpio Huanghe var.…”

Section: Practical Uses Of Lab As An Immunostimulant In Finfish Aquacmentioning

confidence: 99%

See 1 more Smart Citation

Lactic Acid Bacteria in Finfish—An Update

et al. 2018

View full text Add to dashboard Cite

A complex and dynamic community of microorganisms, play important roles within the fish gastrointestinal (GI) tract. Of the bacteria colonizing the GI tract, are lactic acid bacteria (LAB) generally considered as favorable microorganism due to their abilities to stimulating host GI development, digestive function, mucosal tolerance, stimulating immune response, and improved disease resistance. In early finfish studies, were culture-dependent methods used to enumerate bacterial population levels within the GI tract. However, due to limitations by using culture methods, culture-independent techniques have been used during the last decade. These investigations have revealed the presence of Lactobacillus, Lactococcus, Leuconostoc, Enterococcus, Streptococcus, Carnobacterium, Weissella, and Pediococcus as indigenous species. Numerous strains of LAB isolated from finfish are able to produce antibacterial substances toward different potential fish pathogenic bacteria as well as human pathogens. LAB are revealed be the most promising bacterial genera as probiotic in aquaculture. During the decade numerous investigations are performed on evaluation of probiotic properties of different genus and species of LAB. Except limited contradictory reports, most of administered strains displayed beneficial effects on both, growth—and reproductive performance, immune responses and disease resistance of finfish. This eventually led to industrial scale up and introduction LAB-based commercial probiotics. Pathogenic LAB belonging to the genera Streptococcus, Enterococcus, Lactobacillus, Carnobacterium, and Lactococcus have been detected from ascites, kidney, liver, heart, and spleen of several finfish species. These pathogenic bacteria will be addressed in present review which includes their impacts on finfish aquaculture, possible routes for treatment. Finfish share many common structures and functions of the immune system with warm-blooded animals, although apparent differences exist. This similarity in the immune system may result in many shared LAB effects between finfish and land animals. LAB-fed fish show an increase in innate immune activities leading to disease resistances: neutrophil activity, lysozyme secretion, phagocytosis, and production of pro-inflammatory cytokines (IL-1β, IL-6, IL-8, and TNF-α). However, some LAB strains preferentially induces IL-10 instead, a potent anti-inflammatory cytokine. These results indicate that LAB may vary in their immunological effects depending on the species and hosts. So far, the immunological studies using LAB have been focused on their effects on innate immunity. However, these studies need to be further extended by investigating their involvement in the modulation of adaptive immunity. The present review paper focuses on recent findings in the field of isolation and detection of LAB, their administration as probiotic in aquaculture and their interaction with fish immune responses. Furthermore, the mode of action of probiotics on finfish are discussed.

show abstract

Section: Practical Uses Of Lab As An Immunostimulant In Finfish Aquacmentioning

confidence: 99%

“…Some strains of dietary LAB induced IL-10 expression in finfish; Biswas et al ( 2013 ) ( Lb. plantarum 06CC2 treated T. rubripes ), Beck et al ( 2016 ) ( L. lactis BFE920 treated P. olivaceus ), and Maji et al ( 2017 ) (a mixture of Lb. plantarum SM16, Lb.…”

Section: Cytokines As Important Immune Modulators Of Finfish Immunitymentioning

confidence: 99%

Lactic Acid Bacteria in Finfish—An Update

et al. 2018

View full text Add to dashboard Cite

show abstract

“…For those reasons, probiotic viability needs to be verified during storage, and the preservation conditions need to be standardized (Hai 2015a;Ganguly et al 2018). Through this review study, it became clear that the assessment of the viability of the microorganisms is considered an indirect tool for considering active probiotics (Maji et al 2017). However, most papers only tested viability after microorganisms were included in the feed.…”

Section: Discussionmentioning

confidence: 99%

“…Aly et al (2008b) evaluated the safety of B. subtilis and L. acidophilus supplements by intraperitoneal injection in Nile tilapia, with no negative effects being detected. Similarly, Maji et al (2017) assessed probiotic safety by intraperitoneal injection of L. plantarum, L. fermentum, L. brevis and P. pentosaceus in roho labeo fingerlings. Likewise, El-Rhman et al (2009) examined probiotic safety by intraperitoneal injection of M. luteus and Pseudomonas sp.…”

Section: Discussionmentioning

confidence: 99%

“…Giri et al (2014) showed that a mixture of B. subtilis, P. aeruginosa and L. plantarum isolated from the gut of roho labeo enhanced growth, immune response and survival after A. hydrophila challenge in juvenile L. rohita. Similarly, Maji et al (2017) found that a mixture of L. plantarum, L. fermentum, L. brevis, and P. pentosaceus isolated from the gut of freshwater fish, roho labeo (L. rohita), Indian carp (Labeo catla), mrigala carp (Cirrhinus mrigala), silver carp (Hypophthalmichthys molitrix) and grass carp (Ctenopharyngodon Idella), enhanced fingerling L. rohita growth, immune response and survival after challenge with A. hydrophila. Ridha and Azad (2016) demonstrated that a mixture of B. subtilis isolated from Nile tilapia and a commercial L. acidophilus, as compared to treatments with the individual components, enhanced growth and survival in juvenile Nile tilapia after challenge with Proteus vulgaris.…”

Section: Probiotic Sources-autochthonous or Allochthonousmentioning

confidence: 90%

See 1 more Smart Citation

Multistrain probiotics use in main commercially cultured freshwater fish: a systematic review of evidence

Melo‐Bolívar

Pardo

Hume

et al. 2021

Reviews in Aquaculture

View full text Add to dashboard Cite

This review aims to explore developments in the usage of multistrain probiotics in commercial freshwater-cultured fish and to address factors that affect the efficacies of multistrain probiotics to enhance growth parameters, survival after bacterial infection and immune modulation in comparison to monostrain probiotics. From bibliographic searches in Scopus, Web of Science and PubMed, it was possible to select 81 articles that evaluated multistrain probiotics supplementation during in vivo trials in Nile tilapia (Oreochromis niloticus), rainbow trout (Oncorhynchus mykiss), common carp (Cyprinus carpio) and roho labeo (Labeo rohita). Most of the articles showed different benefits, including enhancement of fish growth performance, immune response and resistance against some pathogenic bacteria, such as Aeromonas hydrophila, Streptococcus agalactiae and Streptococcus iniae. However, only 13 journal articles included a monostrain probiotic as a control that would allow direct comparison with a probiotic bacterial mixture to determine if the mixture offered higher benefits in comparison to a monostrain probiotic and a control group without probiotic supplementation. Here we explain the main findings, including the best probiotic mixtures, and some perspectives on multistrain probiotics research and use on a commercial scale.

show abstract